ENTRY       K15379                      KO
NAME        SLC45A3
DEFINITION  solute carrier family 45, member 3
PATHWAY     ko05202  Transcriptional misregulation in cancer
            ko05206  MicroRNAs in cancer
DISEASE     H00024  Prostate cancer
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Human Diseases
              Cancers
               05202 Transcriptional misregulation in cancers
                K15379  SLC45A3; solute carrier family 45, member 3
               05206 MicroRNAs in cancer
                K15379  SLC45A3; solute carrier family 45, member 3
            Transporters [BR:ko02000]
             Solute Carrier Family (SLC)
              SLC45: Putative sugar transporter
               K15379  SLC45A3; solute carrier family 45, member 3
DBLINKS     TC: 2.A.2.4
GENES       HSA: 85414(SLC45A3)
            PTR: 457672(SLC45A3)
            PPS: 100969671(SLC45A3)
            GGO: 101148000(SLC45A3)
            PON: 100454606(SLC45A3)
            MCC: 697420(SLC45A3)
            MCF: 102115659(SLC45A3)
            MMU: 212980(Slc45a3)
            RNO: 304785(Slc45a3)
            CGE: 100755754(Slc45a3)
            HGL: 101704767(Slc45a3)
            TUP: 102474450(SLC45A3)
            CFA: 488575(SLC45A3)
            AML: 100471851(SLC45A3)
            FCA: 101086368(SLC45A3)
            PTG: 102972002(SLC45A3)
            BTA: 524303(SLC45A3)
            BOM: 102279428(SLC45A3)
            PHD: 102321294(SLC45A3)
            CHX: 102182991(SLC45A3)
            SSC: 100626235(SLC45A3)
            CFR: 102509254(SLC45A3)
            BACU: 103004897(SLC45A3)
            LVE: 103077343(SLC45A3)
            ECB: 100050382(SLC45A3)
            MYB: 102253270(SLC45A3)
            MYD: 102754851(SLC45A3)
            PALE: 102892710(SLC45A3)
            MDO: 100019043(SLC45A3)
            SHR: 100915868(SLC45A3)
            GGA: 771751(SLC45A3)
            MGP: 100546984
            FAB: 101805895(SLC45A3)
            PHI: 102103264(SLC45A3)
            APLA: 101796865(SLC45A3)
            FPG: 101913070(SLC45A3)
            FCH: 102049267(SLC45A3)
            CLV: 102097401(SLC45A3)
            ASN: 102376698(SLC45A3)
            AMJ: 102569531(SLC45A3)
            PSS: 102456444(SLC45A3)
            CMY: 102932452(SLC45A3)
            ACS: 100564460(slc45a3)
            PBI: 103049709(SLC45A3)
            XLA: 379697(slc45a3)
            XTR: 100494269(slc45a3) 100496642
            DRE: 100049157(slc45a3) 402971
            TRU: 101068607
            MZE: 101474184 101480221
            OLA: 101158020
            XMA: 102224883
            LCM: 102352542 102365105(SLC45A3)
            CMK: 103182482(slc45a3)
            BFO: BRAFLDRAFT_146172 BRAFLDRAFT_184998 BRAFLDRAFT_79652
            SPU: 576724
REFERENCE   PMID:19293179
  AUTHORS   Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F, Rubin MA
  TITLE     SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion  transcript in prostate cancer.
  JOURNAL   Cancer Res 69:2734-8 (2009)
///
